NASDAQ:ARDS
Aridis Pharmaceuticals Inc. Stock News
$0.0574
-0.0046 (-7.42%)
At Close: May 17, 2024
Aridis Pharmaceuticals (ARDS) Receives a Buy from Maxim Group
02:12pm, Friday, 10'th Apr 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Aridis Pharmaceuticals (ARDS) today and set a price target of $17.00. The company's shares
Aridis Pharmaceuticals (ARDS) Receives a Buy from Maxim Group
02:12pm, Friday, 10'th Apr 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Aridis Pharmaceuticals (ARDS – Research Report) today and set a
Northland Securities Keeps a Buy Rating on Aridis Pharmaceuticals (ARDS)
10:59am, Thursday, 09'th Apr 2020
Northland Securities analyst Carl Byrnes maintained a Buy rating on Aridis Pharmaceuticals (ARDS) today and set a price target of $22.00. The company's
Northland Securities Keeps a Buy Rating on Aridis Pharmaceuticals (ARDS)
10:59am, Thursday, 09'th Apr 2020
Northland Securities analyst
Carl Byrnes
maintained a
Buy
rating on Aridis Pharmaceuticals (
ARDS
–
Research Report
) today and set a price target of
$22.00
. The company’s shares closed last Wedn
Aridis Pharmaceuticals Announces 2019 Fourth Quarter and Year-End Financial Results and Business Update
08:59pm, Wednesday, 08'th Apr 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, toda
RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
10:45am, Thursday, 26'th Mar 2020
RELIEF THERAPEUTICS Holding AG (SIX: RLF) "Relief", together with NeuroRx, a Delaware Corporation. have filed an Investigational New Drug (IND) Application with the US FDA for a phase 2 trial of RLF-1
RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
10:28am, Thursday, 26'th Mar 2020
RELIEF THERAPEUTICS Holding AG (SIX: RLF) "Relief", together with NeuroRx, a Delaware Corporation, have filed an Investigational New Drug (IND) Application with the US FDA for a phase 2 trial of RLF-1
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
11:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) * BioNTech SE - ADR (NASDAQ: BNTX) * Regeneron P
Stocks To Watch: Fading The Fear
12:07pm, Saturday, 07'th Mar 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Aridis Pharmaceuticals to Postpone Investor Day Due to Coronavirus Concerns
09:05pm, Friday, 06'th Mar 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, anno
Aridis Pharmaceuticals to Present at the 32nd Annual ROTH Conference
10:30am, Thursday, 05'th Mar 2020
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, anno